Serum ibuprofen levels of extremely preterm infants treated prophylactically with oral ibuprofen to prevent patent ductus arteriosus

[1]  G. Demirel,et al.  Pharmacological Management of PDA: oral versus intravenous medications. , 2012, Current clinical pharmacology.

[2]  R. Ozdemir,et al.  Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[3]  B. Barzilay,et al.  Pharmacokinetics of oral ibuprofen for patent ductus arteriosus closure in preterm infants , 2011, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[4]  N. Uraş,et al.  Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. , 2011, The Journal of pediatrics.

[5]  A. Thakkinstian,et al.  Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants , 2010, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[6]  F. Demirel,et al.  What are the cut‐off levels for IL‐6 and CRP in neonatal sepsis? , 2010, Journal of clinical laboratory analysis.

[7]  C. Romagnoli,et al.  Does Ibuprofen Increase Neonatal Hyperbilirubinemia? , 2009, Pediatrics.

[8]  M. Khorana,et al.  Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants. , 2008, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[9]  S. Urien,et al.  An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. , 2008, British journal of clinical pharmacology.

[10]  Hsin-Yang Hsieh,et al.  Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial , 2007, Archives of Disease in Childhood Fetal and Neonatal Edition.

[11]  N. Khrouf,et al.  Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. , 2007, American journal of perinatology.

[12]  K. Sathirakul,et al.  Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. , 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[13]  M. Walsh,et al.  Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia , 2005, Pediatrics.

[14]  C. Ahlfors.  Effect of ibuprofen on bilirubin-albumin binding. , 2004, The Journal of pediatrics.

[15]  P. Jolliet,et al.  Population pharmacokinetics of ceftazidime in burn patients. , 2003, British journal of clinical pharmacology.

[16]  P. Sharma,et al.  Pharmacokinetics of Oral Ibuprofen in Premature Infants , 2003, Journal of clinical pharmacology.

[17]  T. Yanowitz,et al.  Prophylactic Indomethacin Reduces Grades III and IV Intraventricular Hemorrhages when Compared to Early Indomethacin Treatment of a Patent Ductus Arteriosus , 2003, Journal of Perinatology.

[18]  G. Kearns,et al.  Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus , 2001 .

[19]  R. Clyman.  Ibuprofen and patent ductus arteriosus. , 2000, The New England journal of medicine.

[20]  Ronald L Thomas,et al.  Ibuprofen Use to Reduce the Incidence and Severity of Bronchopulmonary Dysplasia: A Pilot Study , 2000, Journal of Perinatology.

[21]  A. Varvarigou,et al.  Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant , 1997, Acta paediatrica.

[22]  D. Delpy,et al.  Effect of Indomethacin on Cerebral Oxidized Cytochrome Oxidase in Preterm Infants , 1993, Pediatric Research.

[23]  J. Baan,et al.  Indomethacin-induced changes in renal blood flow velocity waveform in premature infants investigated with color Doppler imaging. , 1991, The Journal of pediatrics.

[24]  D. Delpy,et al.  Effects of indomethacin on cerebral haemodynamics in very preterm infants , 1990, The Lancet.

[25]  M. Nahata,et al.  Pharmacologic management of patent ductus arteriosus. , 1989, Clinical pharmacy.

[26]  R. Cooke,et al.  Early administration of indomethacin to preterm infants. , 1986, Archives of disease in childhood.

[27]  T. Yeh,et al.  Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. , 1981, Pediatrics.

[28]  Bell Mj.  Neonatal necrotizing enterocolitis , 1978 .

[29]  M. J. Bell,et al.  Neonatal Necrotizing Enterocolitis: Therapeutic Decisions Based upon Clinical Staging , 1978, Annals of surgery.